Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Wiley

Showing results (531-540 of 619) with videos related to

Pageof 62
Sort By:
Bioorganic & Medicinal Chemistry|January 23, 2003
3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptorJohn W Huffman, Ross Mabon, Ming Jung Wu, et al.
Journal of the American Academy of Audiology|May 8, 2007
The impact of tinnitus on quality of life in older adultsDavid M Nondahl, Karen J Cruickshanks, Dayna S Dalton, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 18, 2018
Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICAThomas F Gamage, Charlotte E Farquhar, Timothy W Lefever, et al.
Forensic Toxicology|August 22, 2017
In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICARichard C Kevin, Timothy W Lefever, Rodney W Snyder, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 16, 2018
Synthetic Cannabinoid Hydroxypentyl Metabolites Retain Efficacy at Human Cannabinoid ReceptorsThomas F Gamage, Charlotte E Farquhar, Ryan J McKinnie, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indolesJohn W Huffman, Paul V Szklennik, Amanda Almond, et al.
Addiction Biology|April 21, 2012
The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxietyJesse R Schank, Andrea L Goldstein, Kelly E Rowe, et al.
Innovations (Philadelphia, Pa.)|March 23, 2012
Minimally invasive versus open mitral valve surgery: a consensus statement of the international society of minimally invasive coronary surgery (ISMICS) 2010Volkmar Falk, Davy C H Cheng, Janet Martin, et al.
Pharmacology, Biochemistry, and Behavior|February 22, 2023
The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolismDavid B Finlay, Warwick Mackie, Hunter D J Webb, et al.
AJR. American Journal of Roentgenology|February 1, 1976
Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized studyT C Lo, A L Wiley, F J Ansfield, et al.
Pageof 62

Showing results (531-540 of 619) with videos related to

Sort By:
Pageof 62
Bioorganic & Medicinal Chemistry|January 23, 2003
3-Indolyl-1-naphthylmethanes: new cannabimimetic indoles provide evidence for aromatic stacking interactions with the CB(1) cannabinoid receptorJohn W Huffman, Ross Mabon, Ming Jung Wu, et al.
Journal of the American Academy of Audiology|May 8, 2007
The impact of tinnitus on quality of life in older adultsDavid M Nondahl, Karen J Cruickshanks, Dayna S Dalton, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 18, 2018
Molecular and Behavioral Pharmacological Characterization of Abused Synthetic Cannabinoids MMB- and MDMB-FUBINACA, MN-18, NNEI, CUMYL-PICA, and 5-Fluoro-CUMYL-PICAThomas F Gamage, Charlotte E Farquhar, Timothy W Lefever, et al.
Forensic Toxicology|August 22, 2017
In vitro and in vivo pharmacokinetics and metabolism of synthetic cannabinoids CUMYL-PICA and 5F-CUMYL-PICARichard C Kevin, Timothy W Lefever, Rodney W Snyder, et al.
The Journal of Pharmacology and Experimental Therapeutics|December 16, 2018
Synthetic Cannabinoid Hydroxypentyl Metabolites Retain Efficacy at Human Cannabinoid ReceptorsThomas F Gamage, Charlotte E Farquhar, Ryan J McKinnie, et al.
Bioorganic & Medicinal Chemistry Letters|July 12, 2005
1-Pentyl-3-phenylacetylindoles, a new class of cannabimimetic indolesJohn W Huffman, Paul V Szklennik, Amanda Almond, et al.
Addiction Biology|April 21, 2012
The kappa opioid receptor antagonist JDTic attenuates alcohol seeking and withdrawal anxietyJesse R Schank, Andrea L Goldstein, Kelly E Rowe, et al.
Innovations (Philadelphia, Pa.)|March 23, 2012
Minimally invasive versus open mitral valve surgery: a consensus statement of the international society of minimally invasive coronary surgery (ISMICS) 2010Volkmar Falk, Davy C H Cheng, Janet Martin, et al.
Pharmacology, Biochemistry, and Behavior|February 22, 2023
The piperazine analogue para-fluorophenylpiperazine alters timing of the physiological effects of the synthetic cannabinoid receptor agonist AMB-FUBINACA, without changing its discriminative stimulus, signalling effects, or metabolismDavid B Finlay, Warwick Mackie, Hunter D J Webb, et al.
AJR. American Journal of Roentgenology|February 1, 1976
Combined radiation therapy and 5-fluorouracil for advanced squamous cell carcinoma of the oral cavity and oropharynx: a randomized studyT C Lo, A L Wiley, F J Ansfield, et al.
Pageof 62